Yahoo
OTC Markets OTCPK - Delayed Quote USD

Shionogi & Co., Ltd. (SGIOF)

20.85 0.00 (0.00%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for SGIOF
  • Previous Close 20.85
  • Open 20.85
  • Bid 17.11 x 40000
  • Ask 20.85 x 40000
  • Day's Range 20.85 - 20.85
  • 52 Week Range 15.21 - 26.00
  • Volume 100
  • Avg. Volume 32
  • Market Cap (intraday) 17.747B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 11.58
  • EPS (TTM) 1.80
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 0.49 (2.86%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est --

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.

www.shionogi.com

6,223

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

SGIOF
40.57%
Nikkei 225 (^N225)
25.73%

1-Year Return

SGIOF
18.06%
Nikkei 225 (^N225)
23.31%

3-Year Return

SGIOF
47.96%
Nikkei 225 (^N225)
106.18%

5-Year Return

SGIOF
6.37%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 187.07B
Earnings 21.85B
Profit Margin 11.68%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
50B
100B
150B
20.0%
30.0%
40.0%
50.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    37.85%

  • Return on Assets (ttm)

    5.92%

  • Return on Equity (ttm)

    15.18%

  • Revenue (ttm)

    637.09B

  • Net Income Avi to Common (ttm)

    241.16B

  • Diluted EPS (ttm)

    1.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    376.48B

  • Total Debt/Equity (mrq)

    39.10%

  • Levered Free Cash Flow (ttm)

    135.49B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: